🔎 Trials Near Me

Home › Diffuse Large B-Cell Lymphoma › California › Sacramento

Diffuse Large B-Cell Lymphoma clinical trials in Sacramento, CA

8 studies for Diffuse Large B-Cell Lymphoma are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

RecruitingPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05272384

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

RecruitingPhase 2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT06500273

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

RecruitingPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Jul 17, 2026 · NCT05052528

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

RecruitingPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT06015880

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

RecruitingPhase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Jul 8, 2026 · NCT06854159

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

RecruitingPhase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT06905509

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

RecruitingPhase 1/2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 to 70 · All sexes · Updated Mar 10, 2026 · NCT05256641

Diffuse Large B-Cell Lymphoma trials in other cities

Other studies in Sacramento

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.